Correlation Between Longboard Pharmaceuticals and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Longboard Pharmaceuticals and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longboard Pharmaceuticals and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longboard Pharmaceuticals and Monopar Therapeutics, you can compare the effects of market volatilities on Longboard Pharmaceuticals and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longboard Pharmaceuticals with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longboard Pharmaceuticals and Monopar Therapeutics.
Diversification Opportunities for Longboard Pharmaceuticals and Monopar Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Longboard and Monopar is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Longboard Pharmaceuticals and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Longboard Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longboard Pharmaceuticals are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Longboard Pharmaceuticals i.e., Longboard Pharmaceuticals and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Longboard Pharmaceuticals and Monopar Therapeutics
Given the investment horizon of 90 days Longboard Pharmaceuticals is expected to generate 107.3 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Longboard Pharmaceuticals is 41.59 times less risky than Monopar Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 1,457 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 796.00 from holding Monopar Therapeutics or generate 54.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Longboard Pharmaceuticals vs. Monopar Therapeutics
Performance |
| Timeline |
| Longboard Pharmaceuticals |
| Monopar Therapeutics |
Longboard Pharmaceuticals and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Longboard Pharmaceuticals and Monopar Therapeutics
The main advantage of trading using opposite Longboard Pharmaceuticals and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longboard Pharmaceuticals position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Longboard Pharmaceuticals vs. Molecular Partners AG | Longboard Pharmaceuticals vs. MediciNova | Longboard Pharmaceuticals vs. Anebulo Pharmaceuticals | Longboard Pharmaceuticals vs. Champions Oncology |
| Monopar Therapeutics vs. Cue Biopharma | Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Lantern Pharma | Monopar Therapeutics vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |